Donation after Brain Death (DBD) - Expanded Donor Management

Quick Answer

Donation after Brain Death (DBD) is the process of organ retrieval following formal determination of death by neurological criteria. Brain death triggers a biphasic autonomic response: an initial catecholamine storm (massive sympathetic discharge with hypertension, tachycardia, and myocardial stunning) followed by catecholamine depletion (loss of sympathetic tone, hypotension, hypothermia, and hypopituitarism). Effective donor management targets the 4H bundle (Hemodynamics, Hormones, Homeostasis, Hematology) and achieves the 10 donor optimization goals. Key interventions include: vasopressin for diabetes insipidus and vasoplegia, methylprednisolone for systemic inflammation, lung-protective ventilation (Vt 6-8 mL/kg, PEEP 8-10 cmH2O), and organ-specific optimization. In Australia/NZ, donor management follows ANZICS/TSANZ guidelines and is coordinated through the DonateLife network. Implementation of standardized donor management bundles increases organs transplanted per donor from 3.5 to 4.5+ and improves graft function.[1-4]

---

CICM Exam Focus

Second Part Written Exam

DBD donor management is a high-yield CICM topic appearing across multiple exam formats:

Common SAQ Topics

• "Outline the physiological consequences of brain death relevant to donor management"
• "Describe the hormonal resuscitation protocol for a brain-dead organ donor"
• "Discuss the management priorities for optimizing lung procurement"
• "Compare standard criteria and extended criteria donors"
• "Outline the management of cardiovascular instability in a potential organ donor"

Viva Scenarios

• Managing refractory hypotension in a brain-dead donor with diabetes insipidus
• Optimizing a marginal cardiac donor with borderline ejection fraction
• Communication with family during donor management
• Troubleshooting poor lung oxygenation in a potential lung donor
• Evidence base for hormonal resuscitation therapy

---

Key Points

Clinical

• Brain death triggers biphasic autonomic response: catecholamine storm followed by catecholamine depletion
• Diabetes insipidus occurs in 70-90% of brain-dead donors due to ADH deficiency
• 4H Bundle: Hemodynamics, Hormones, Homeostasis, Hematology
• 10 Donor Optimization Goals: MAP >65, HR 60-120, UO 0.5-3 mL/kg/h, Hb >70, PaO2 >100, glucose <10, Na 130-150, temp >35°C, pH 7.35-7.45, CVP 4-10
• Vasopressin is first-line for both DI and hemodynamic support (reduces catecholamine requirements)
• Methylprednisolone 15 mg/kg IV is recommended for all donors (reduces inflammation, improves lung procurement)

Evidence Base

• Rosendale 2003: Hormonal resuscitation increases cardiac procurement by 22%
• Mascia 2010 (JAMA): Lung-protective ventilation increases lung procurement from 27% to 54%
• Powner 2004: Aggressive donor management increases organs per donor by 1-2
• Crystal City Consensus 2014: Standardized donor management targets
• Pfeifer 2023 (NEJM): T4 replacement shows no benefit vs placebo in RCT

Australian/NZ Context

• ANZICS Statement on Death and Organ Donation (Edition 4.1, 2021) - primary reference
• TSANZ Clinical Guidelines - transplant-specific recommendations
• DonateLife network - national coordination of organ donation
• ~500-600 DBD donors/year in Australia; 80-85% of all deceased donors
• Average 3.8-4.2 organs per DBD donor in Australia (target: >4.5 with optimal management)

---

Epidemiology

Australian Organ Donation Statistics (2023)

Causes of Brain Death in Donors

Donor Conversion Rates

The donor conversion rate measures the proportion of potential donors who become actual organ donors:

• Australia (2023): 68% consent rate; 85% of consented donors proceed to retrieval
• Key conversion barriers: Family refusal (32%), medical unsuitability (15%), organ-specific decline (12%)
• Optimal donor management can convert 20-25% of initially marginal donors to suitable donors[5-7]

---

Pathophysiology

Biphasic Autonomic Response to Brain Death

Brain death results from severe intracranial hypertension exceeding cerebral perfusion pressure, leading to brainstem herniation and global cerebral ischemia. This triggers a characteristic biphasic autonomic response:[12-15]

Phase 1: Catecholamine Storm (Autonomic Storm)

Timing: Minutes to hours following brainstem herniation

Mechanism:

• Rostral-to-caudal herniation causes progressive loss of descending inhibitory pathways
• Ischemic injury to medullary vasomotor center triggers massive sympathetic discharge
• Cushing reflex (hypertension + bradycardia) as terminal brainstem response
• Catecholamine levels increase 5-10 fold (noradrenaline, adrenaline)

Cardiovascular Effects:

Pulmonary Effects:

• Neurogenic pulmonary edema (NPE) in 10-20% of donors
• Mechanism: Increased pulmonary vascular pressure + endothelial injury
• Results in refractory hypoxemia and reduced lung procurement eligibility

Cardiac Histopathology:

• Contraction band necrosis (hypercontraction of myofibrils)
• Myofibrillar degeneration
• Inflammatory cell infiltration
• Similar to catecholamine-induced (stress) cardiomyopathy
• 70-80% reversibility with optimal donor management[14]

Phase 2: Catecholamine Depletion

Timing: Hours following brain death (typically 2-6 hours after herniation)

Mechanism:

• Depletion of catecholamine stores from sustained release
• Loss of descending sympathetic outflow from brainstem
• Vasodilatory collapse without autonomic regulation

Cardiovascular Manifestations:

Hypothalamic-Pituitary Axis Failure (Hypopituitarism)

Brain death causes infarction of the hypothalamus and pituitary gland, resulting in complete loss of hypothalamic-pituitary function:[17-19]

Diabetes Insipidus (DI) - Central

Pathophysiology: Loss of ADH secretion from posterior pituitary

Diagnostic Criteria:

• Urine output >4 mL/kg/h (or >300 mL/h)
• Urine specific gravity <1.005
• Urine osmolality <200 mOsm/kg
• Serum osmolality >300 mOsm/kg
• Rising serum sodium (>145 mmol/L)

Consequences if Untreated:

• Profound hypovolemia → cardiovascular collapse
• Severe hypernatremia → cellular dehydration, organ injury
• Hypernatremia >155 mmol/L associated with 3-fold increased liver graft failure[20]

Systemic Inflammatory Response

Brain death triggers a massive systemic inflammatory response independent of infection:[21-23]

Inflammatory Mediators:

• IL-6: 50-100× elevation (correlates with graft dysfunction)
• TNF-α: 10-20× elevation
• IL-1β, IL-8: Significant elevation
• Complement activation: C3a, C5a elevation
• Tissue factor release: Triggers DIC in 30-40% of donors

Consequences of Inflammation:

1. Endothelial activation: Increased vascular permeability, edema
2. Organ immunogenicity: Priming of innate immune system → increased rejection risk
3. Coagulopathy: DIC in 30-40% of donors
4. Multi-organ dysfunction: Hepatic, renal, pulmonary injury

Methylprednisolone Mechanism:

• Suppresses NF-κB signaling
• Reduces IL-6, TNF-α, IL-1β production
• Stabilizes endothelial membranes
• Improves catecholamine responsiveness
• Reduces primary graft dysfunction across all organs[22,23]

Temperature Dysregulation

Mechanism: Loss of hypothalamic thermoregulation

Manifestations:

• Hypothermia (<35°C) in 50-70% of brain-dead donors
• Poikilothermia (body temperature follows ambient)
• Shivering abolished (brainstem dysfunction)

Consequences of Hypothermia:

• Coagulopathy (enzyme dysfunction <34°C)
• Cardiac arrhythmias (especially <32°C)
• Impaired drug metabolism
• Tissue hypoperfusion
• Insulin resistance

---

Donor Optimization Bundle

The 4H Framework

The 4H Bundle provides a systematic approach to donor management:[24-26]

10 Donor Optimization Goals

The 10 Goals provide specific physiological targets:[27-29]

Crystal City Consensus (2014)

The Crystal City Consensus represents international expert agreement on donor management targets:[30]

Key Recommendations:

1. Hemodynamic Management:

   • Target MAP 60-80 mmHg (not >100 mmHg as older "Rule of 100s")
   • Vasopressin as first-line for hypotension and DI
   • Minimize catecholamine use (target noradrenaline <0.1 mcg/kg/min)
   • CVP 4-10 mmHg (lower for lung donors)

2. Hormonal Resuscitation:

   • Methylprednisolone 15 mg/kg IV for all donors
   • Vasopressin for DI and hemodynamic support
   • T3/T4 selective use (cardiac donors with dysfunction)

3. Ventilation:

   • Lung-protective ventilation (Vt 6-8 mL/kg IBW)
   • PEEP 8-10 cmH2O
   • Recruitment maneuvers for atelectasis

4. Glycemic Control:

   • Target 6-10 mmol/L (avoid both hyper- and hypoglycemia)

5. Temperature:

   • Active warming to maintain >35.5°C

---

Hemodynamic Management

Fluid Resuscitation

Goals:

• Restore euvolemia (CVP 4-10 mmHg)
• Replace losses from diabetes insipidus
• Avoid fluid overload (impairs lung procurement)

Fluid Selection:

Fluid Assessment:

• Dynamic parameters: Pulse pressure variation (PPV), stroke volume variation (SVV) if ventilated with Vt >8 mL/kg
• Static parameters: CVP (limited accuracy), clinical assessment
• Echocardiography: IVC collapsibility, stroke volume response to fluid
• Lactate clearance: Trend indicates perfusion adequacy

Vasopressor and Inotrope Selection

Vasopressin - First-Line Agent:[31-34]

Noradrenaline - Second-Line Vasopressor:

Inotropes:

Dopamine - Historical Use:

• Previously used as first-line in donor management
• No longer recommended: No benefit over noradrenaline, more arrhythmogenic
• Low-dose "renal-protective" dopamine: No evidence of benefit[35]

Echocardiography in Donor Assessment

Timing:

• Baseline within 6 hours of brain death declaration
• Repeat at 12-24 hours if initially abnormal
• Pre-retrieval assessment for cardiac donors

Assessment Parameters:

Catecholamine-Induced Myocardial Stunning:

• EF 30-45% during catecholamine storm may improve to >50% over 12-24 hours
• Serial echocardiography recommended for borderline donors
• 70-80% of stunned hearts recover with optimal management[36]

---

Hormonal Resuscitation

Complete Hormonal Replacement Protocol

The full hormonal resuscitation protocol includes four components:[37-42]

1. Methylprednisolone (RECOMMENDED FOR ALL DONORS)

Key Evidence:

• Follette 1998: Methylprednisolone improves oxygenation in donors (PaO2/FiO2 ratio)
• Kotsch 2008: Reduces hepatic ischemia-reperfusion injury markers
• Amatschek 2012: Meta-analysis confirms benefit across organ types[37-39]

2. Vasopressin/Desmopressin (RECOMMENDED)

For Diabetes Insipidus:

For Hemodynamic Support:

• Vasopressin 0.01-0.04 units/min
• Titrate to MAP 65-80 mmHg
• Target noradrenaline <0.1 mcg/kg/min

Targets:

• Urine output 0.5-3 mL/kg/h
• Serum sodium 130-150 mmol/L
• Correct hypernatremia slowly (<12 mmol/L per 24 hours)

3. Thyroid Hormone (T3/T4) - CONTROVERSIAL

4. Insulin (RECOMMENDED)

Evidence: NICE-SUGAR trial findings apply; moderate control (6-10 mmol/L) optimal[43]

Summary: Hormonal Resuscitation Evidence

---

Ventilation Management for Lung Procurement

Lung-Protective Ventilation Strategy

Lung-protective ventilation is essential for maximizing lung procurement:[44-47]

IBW Calculation:

• Male: 50 + 0.91 × (height in cm - 152.4)
• Female: 45.5 + 0.91 × (height in cm - 152.4)

Key Evidence: Mascia 2010 (JAMA)

Lung Donor Management (LDM) Trial:

• 118 brain-dead potential lung donors randomized to:
  • Conventional ventilation (Vt 10-12 mL/kg, PEEP 3-5 cmH2O, closed suction)
  • Lung-protective strategy (Vt 6-8 mL/kg, PEEP 8-10 cmH2O, recruitment, apnea test with CPAP)

Results:

• Lung procurement rate: 54% (protective) vs 27% (conventional), p=0.004
• Organs transplanted: 95 vs 52
• 1-year graft survival: No difference (80% vs 76%)

Conclusion: Lung-protective ventilation doubles lung procurement rate without affecting graft outcomes[44]

Recruitment Maneuvers

Indications:

• After any circuit disconnection (suctioning, transport)
• Declining PaO2/FiO2 ratio
• Before final lung assessment for donation

Techniques:

1. Sustained Inflation (most common):

   • CPAP 40 cmH2O for 40 seconds
   • Simple, effective, widely used

2. Incremental PEEP:

   • Increase PEEP by 5 cmH2O increments to 20-25 cmH2O
   • Hold 2 minutes at each level
   • Gradually decrease to baseline

3. Pressure Control Recruitment:

   • PCV mode: PEEP 25 cmH2O, driving pressure 15 cmH2O for 2 minutes
   • Return to baseline settings

Post-Recruitment:

• Maintain PEEP 8-10 cmH2O to prevent de-recruitment
• Recheck ABG within 30 minutes
• Repeat if PaO2 declines

Apnea Testing Modifications for Lung Donors

Standard Apnea Test: Disconnect from ventilator → alveolar collapse → de-recruitment

Modified Approach for Lung Donors:

• Perform with CPAP 5-10 cmH2O instead of complete disconnection
• Use T-piece with CPAP if possible
• Maintain PEEP throughout to prevent collapse
• Immediate recruitment maneuver after test completion

Oxygenation Targets for Lung Procurement

Improving Oxygenation:

1. Recruitment maneuvers
2. PEEP optimization (up to 12-15 cmH2O if needed)
3. Prone positioning (consider for refractory hypoxemia)
4. Diuresis (if pulmonary edema present)
5. Bronchoscopy (clear secretions, assess for aspiration)

Bronchoscopy in Lung Donors

Indications:

• All potential lung donors (routine assessment)
• Suspected aspiration
• Mucus plugging or lobar collapse
• Assessment for donation decision

Findings Affecting Donation:

---

Organ-Specific Optimization

Cardiac Donor Optimization

Goal: Recover stunned myocardium, achieve EF >45%[48-50]

Assessment:

• Baseline echocardiography within 6 hours of brain death
• Serial echo at 12-24 hours if initially abnormal
• Coronary angiography if age >50 or CAD risk factors

Management Priorities:

Recovery Potential:

• 70-80% of hearts with EF 30-45% during catecholamine storm recover to EF >50%
• Serial echo at 12-24 hours essential for borderline donors
• Consider organ when EF >40% with improving trajectory[48]

Lung Donor Optimization

Goal: PaO2/FiO2 >300 mmHg on PEEP 5, FiO2 0.4[44-47]

Assessment:

• CXR (clear fields preferred)
• ABG on standardized settings (FiO2 1.0, PEEP 5 cmH2O for 30 min → measure PaO2)
• Bronchoscopy (airways, secretions, aspiration)

Management Priorities:

Extended Criteria Lung Donors:

• Age >55 years
• Smoking history >20 pack-years
• PaO2/FiO2 200-300 mmHg
• Mild aspiration/infiltrates
• CXR abnormalities

Liver Donor Optimization

Goal: Maintain perfusion, control sodium, minimize ischemia[51-53]

Assessment:

• LFTs (ALT, AST, bilirubin)
• INR, albumin
• CT for steatosis assessment (>30% macrovesicular steatosis = concern)

Management Priorities:

Kidney Donor Optimization

Goal: Maintain renal perfusion, avoid nephrotoxins, preserve function[54,55]

Assessment:

• Creatinine (baseline and trend)
• Urine output
• Kidney ultrasound (size, cysts, obstruction)

Management Priorities:

Extended Criteria Kidney Donors (ECD):

• Age >60 years, OR
• Age 50-59 years with ≥2 of:
  • Hypertension
  • Terminal creatinine >1.5 mg/dL (>133 μmol/L)
  • Cerebrovascular accident as cause of death

Kidney Donor Profile Index (KDPI):

• KDPI 0-20%: Excellent quality
• KDPI 21-85%: Standard quality
• KDPI >85%: High-risk (ECD equivalent)

Pancreas Donor Optimization

Goal: Avoid pancreatitis, maintain glycemic control[56]

Assessment:

• Amylase, lipase (exclude pancreatitis)
• Blood glucose, HbA1c
• BMI (obesity = steatosis risk)

Management Priorities:

Pancreas Donor Selection:

• Age 10-50 years (ideal)
• BMI <30 kg/m²
• No diabetes mellitus
• Normal amylase/lipase
• Hemodynamically stable

---

Marginal and Extended Criteria Donors

Definition of Extended Criteria Donors (ECD)

General ECD Criteria:[57-59]

Organ-Specific ECD Criteria:

Management of Marginal Donors

Key Principles:

1. Aggressive optimization - more intensive management may convert marginal to acceptable
2. Extended observation - allow time for recovery (especially cardiac)
3. Machine perfusion - assess and improve organ function ex vivo
4. Appropriate recipient matching - higher-risk donors to higher-risk recipients

Specific Strategies:

Machine Perfusion Technologies

Ex Vivo Organ Perfusion allows assessment and optimization of marginal organs:[60,61]

Impact: Machine perfusion can increase marginal donor utilization by 20-30%

---

Australian/New Zealand Context

ANZICS Statement on Death and Organ Donation (Edition 4.1, 2021)

Key Recommendations:[62]

1. Brain Death Determination:

   • Two qualified practitioners (at least one with ≥5 years specialist experience)
   • Standardized clinical testing + apnea test
   • Ancillary testing if clinical exam incomplete

2. Donor Management Bundle:

   • Methylprednisolone 15 mg/kg IV
   • Vasopressin for DI and hemodynamic support
   • Lung-protective ventilation
   • Temperature >35.5°C
   • Euglycemia (6-10 mmol/L)

3. Family Communication:

   • Decoupled approach (death notification separate from donation request)
   • DonateLife coordinators for donation discussions
   • Extended time for Aboriginal and Torres Strait Islander families

TSANZ Clinical Guidelines

The Transplantation Society of Australia and New Zealand (TSANZ) provides organ-specific recommendations:[63]

Kidney:

• KDPI calculation for all donors
• Accept ECD kidneys for appropriate recipients
• Machine perfusion for ECD/DCD kidneys

Liver:

• Sodium <155 mmol/L at retrieval
• Steatosis assessment (biopsy if CT suggests >30%)
• Consider NMP for marginal livers

Heart:

• Serial echo for borderline EF
• Coronary angiography if age >50 or risk factors
• Consider ex vivo perfusion for marginal hearts

Lung:

• Lung-protective ventilation mandatory
• Bronchoscopy for all potential donors
• EVLP for marginal lungs at transplant centers

DonateLife Network

Structure:[64]

• DonateLife Australia: National coordination body
• State/Territory Agencies: NSW/ACT, VIC, QLD, WA, SA, TAS, NT
• Specialist Donation Coordinators: Present in major hospitals
• Specialist Donor Nurses: ICU-based donor management expertise

Services:

• 24/7 referral line for potential donors
• Family support and communication
• Donor management support
• Organ allocation coordination
• Recipient notification and logistics
• Post-donation family follow-up

Key Metrics (2023):

• 542 deceased donors nationally
• 3.9 organs transplanted per donor
• 68% family consent rate
• Target: 25 dpmp, >4.5 organs per donor

---

Family Support During Donation

Communication Framework

Decoupled Approach:[65,66]

1. Death Notification (treating team):

   • Clear, unambiguous language: "I need to tell you that [patient name] has died"
   • Allow time for processing and questions
   • Confirm understanding of brain death

2. Transition (after processing):

   • "Would you like me to invite our organ donation coordinator to speak with you about options?"
   • Respect refusal without pressure

3. Donation Discussion (DonateLife coordinator):

   • Reconfirm understanding of death
   • Explain donation process, options
   • Address specific concerns
   • Allow family to specify organs/tissues
   • Written consent if proceeding

Evidence for Decoupling:

• Gortmaker (JAMA): 60% consent with decoupling vs 18% simultaneous
• OPO coordinators achieve 70-80% consent vs 30-40% for treating physicians

Cultural Considerations

Aboriginal and Torres Strait Islander Families:

• Involve Aboriginal Health Workers/Liaison Officers early
• Allow extended time for family and community decision-making
• Respect cultural protocols around death and the body
• Elders may be key decision-makers
• Community consultation may be required

Māori Families:

• Whānau (extended family) involvement essential
• Kaumātua (Elders) may guide decisions
• Consider tikanga (cultural protocols) specific to iwi
• Māori Health Workers for support

Other Cultural/Religious Considerations:

• Provide interpreter services as needed
• Offer spiritual/religious support
• Address specific concerns (body integrity, afterlife beliefs)
• Some religions support donation; provide accurate information

Bereavement Support

During Hospital Stay:

• Continuous nursing support
• Social work involvement
• Spiritual care if requested
• Private space for family
• Opportunity to spend time with patient (before and after retrieval)

Post-Donation:

• Bereavement counseling referral
• Donor family support groups (DonateLife)
• Option to receive information about recipients (with consent)
• Memorial services (DonateLife Thank You Day)
• Anniversary recognition

---

CICM SAQ Practice Questions

SAQ 1: Physiological Management of Brain-Dead Donor (20 marks)

Question: A 45-year-old male is declared brain dead following a massive subarachnoid hemorrhage. His family has consented to organ donation. His current observations are: BP 75/40 mmHg on noradrenaline 0.3 mcg/kg/min, HR 52 bpm, urine output 650 mL/h, serum sodium 162 mmol/L, temperature 34.2°C.

a) Describe the pathophysiology of the hemodynamic and metabolic derangements observed. (6 marks) b) Outline your management of this donor to optimize organ function. (10 marks) c) What specific interventions would you prioritize for liver procurement? (4 marks)

---

Model Answer:

a) Pathophysiology (6 marks)

Hemodynamic Instability (3 marks):

• Brain death causes biphasic autonomic response (0.5)
• Initial catecholamine storm (sympathetic surge) followed by catecholamine depletion (0.5)
• Loss of descending sympathetic outflow from brainstem → profound vasodilation (0.5)
• Myocardial stunning from catecholamine-induced cardiomyopathy → reduced cardiac output (0.5)
• Impaired response to exogenous catecholamines (receptor downregulation) (0.5)
• Bradycardia from loss of sympathetic tone/vagal predominance (0.5)

Diabetes Insipidus and Hypernatremia (2 marks):

• Loss of ADH (vasopressin) secretion from posterior pituitary infarction (0.5)
• Results in central diabetes insipidus → massive polyuria (>300 mL/h) (0.5)
• Free water loss without ADH-mediated reabsorption → hypernatremia (0.5)
• Hypovolemia from polyuria exacerbates hypotension (0.5)

Hypothermia (1 mark):

• Loss of hypothalamic thermoregulation (0.5)
• Poikilothermia (body temperature follows ambient) (0.5)

---

b) Management to Optimize Organ Function (10 marks)

Hemodynamic Optimization (4 marks):

• Vasopressin (1): First-line agent; start 0.5-2 units/h infusion
  • Replaces ADH deficiency (treats DI)
  • Provides vasoconstriction (reduces catecholamine requirements)
  • "Target: MAP 65-80 mmHg, UO 0.5-3 mL/kg/h"
• Wean noradrenaline (0.5): Target <0.1 mcg/kg/min (high-dose catecholamines impair graft function)
• Fluid resuscitation (1): Replace free water losses with 0.45% saline or 5% dextrose
• Target CVP (0.5): 4-10 mmHg (euvolemia)
• Inotrope consideration (0.5): If cardiac output remains low (EF <45% on echo), add dobutamine 2-10 mcg/kg/min
• Echocardiography (0.5): Assess LV function, volume status, exclude structural abnormality

Hormonal Resuscitation (2 marks):

• Methylprednisolone (0.5): 15 mg/kg IV (up to 1,000 mg) once
  • Reduces systemic inflammation (IL-6, TNF-α)
  • Improves catecholamine responsiveness
  • Increases organ procurement
• Vasopressin/DDAVP (0.5): Already covered above for hemodynamics and DI
• Insulin infusion (0.5): Target glucose 6-10 mmol/L
• T3/T4 (0.5): Consider if EF <45% despite above measures (evidence is controversial post-Pfeifer 2023)

Sodium Correction (1 mark):

• Correct hypernatremia slowly (0.5): <12 mmol/L per 24 hours
• Replace free water deficit (0.5): Calculate deficit and replace with hypotonic fluids

Temperature Management (1 mark):

• Active warming (0.5): Forced-air warming blanket (Bair Hugger), warm IV fluids
• Target >35.5°C (0.5)

Ventilation (1 mark):

• Lung-protective ventilation (0.5): Vt 6-8 mL/kg IBW, PEEP 8-10 cmH2O
• Recruitment maneuvers (0.5) if hypoxemic or after disconnections

Monitoring and Support (1 mark):

• Arterial line, central venous catheter (0.5)
• Serial ABGs, electrolytes every 2-4 hours (0.5)

---

c) Liver-Specific Interventions (4 marks)

• Sodium control (1.5): Critical priority; Na >155 mmol/L associated with 3× increased primary graft non-function

  • Target 130-150 mmol/L
  • Correct slowly (<12 mmol/L per 24 hours) to avoid osmotic hepatocyte injury

• Perfusion maintenance (1): MAP >65 mmHg; minimize catecholamines (hepatic artery vasoconstriction)

  • Vasopressin preferred over noradrenaline

• Glycemic control (0.5): Target 6-10 mmol/L; hyperglycemia worsens hepatic ischemia-reperfusion

• Coagulopathy correction (0.5): FFP if INR >2 (reflects hepatic synthetic function)

• Avoid hepatotoxins (0.5): Review medications; minimize any potential hepatotoxic agents

---

SAQ 2: Lung Donor Optimization (20 marks)

Question: A 38-year-old female is declared brain dead following severe traumatic brain injury from a motor vehicle collision. She is a registered organ donor and her family has consented to donation including lungs. Current ABG on FiO2 1.0, PEEP 5 cmH2O shows pH 7.35, PaCO2 42 mmHg, PaO2 180 mmHg (PaO2/FiO2 = 180). CXR shows bilateral lower lobe infiltrates.

a) Discuss the physiological basis for impaired lung function in brain-dead donors. (6 marks) b) Outline your management strategy to optimize this patient for lung procurement. (10 marks) c) What defines an extended criteria lung donor, and how would you counsel the transplant team? (4 marks)

---

Model Answer:

a) Physiological Basis for Impaired Lung Function (6 marks)

Neurogenic Pulmonary Edema (NPE) (2 marks):

• Occurs in 10-20% of brain-dead donors (0.5)
• Mechanism: Catecholamine storm → massive sympathetic discharge → severe systemic hypertension (0.5)
• Redistribution of blood to pulmonary circulation → increased pulmonary capillary pressure (0.5)
• Endothelial injury → increased alveolar-capillary permeability → protein-rich edema (0.5)

Aspiration (1 mark):

• Common in trauma patients (impaired consciousness before intubation) (0.5)
• Chemical pneumonitis from gastric contents (0.5)

Ventilator-Associated Injury (1 mark):

• Pre-brain death ventilation may not have been lung-protective (0.5)
• High tidal volumes, low PEEP → volutrauma, atelectrauma (0.5)

Systemic Inflammation (1 mark):

• Brain death triggers massive cytokine release (IL-6, TNF-α) (0.5)
• Systemic inflammation injures pulmonary endothelium → ARDS-like picture (0.5)

Other Factors (1 mark):

• Fluid overload from aggressive resuscitation (0.5)
• Infection/pneumonia (especially if prolonged ICU stay) (0.5)

---

b) Management Strategy for Lung Optimization (10 marks)

Lung-Protective Ventilation (3 marks):

• Tidal volume (0.5): 6-8 mL/kg ideal body weight (prevents volutrauma)
• PEEP (0.5): Increase to 8-10 cmH2O (prevents atelectrauma, maintains recruitment)
• Plateau pressure (0.5): Target <30 cmH2O
• Driving pressure (0.5): Target <15 cmH2O (independent predictor of lung injury)
• FiO2 (0.5): Wean to lowest achieving PaO2 >100 mmHg (prevent oxygen toxicity)
• RR (0.5): Adjust to maintain PaCO2 35-45 mmHg

Recruitment Maneuvers (2 marks):

• Perform recruitment to open atelectatic lung (0.5)
• Technique: Sustained inflation (CPAP 40 cmH2O for 40 seconds) OR incremental PEEP recruitment (0.5)
• Repeat after any circuit disconnection (0.5)
• Maintain PEEP 8-10 cmH2O post-recruitment to prevent de-recruitment (0.5)

Fluid Management (2 marks):

• Target euvolemia to slight negative balance (0.5): CVP 4-8 mmHg (lower for lung donors)
• Avoid fluid overload (0.5): Worsens pulmonary edema
• Consider diuresis (0.5): Furosemide 20-40 mg IV if CVP >10 or clinical pulmonary edema
• Balance with perfusion (0.5): May need vasopressor increase if diuresing

Methylprednisolone (1 mark):

• 15 mg/kg IV once (0.5)
• Reduces inflammation, improves oxygenation, increases lung procurement (0.5)

Bronchoscopy (1 mark):

• Therapeutic: Clear secretions, mucus plugs (0.5)
• Diagnostic: Assess for aspiration, infection, mucosal injury (0.5)

Tracheobronchial Toilet (0.5 marks):

• Regular suctioning (gentle, avoid mucosal trauma)
• Head of bed elevation 30°

Serial Assessment (0.5 marks):

• Repeat ABG after interventions
• Target PaO2/FiO2 >300 mmHg on standardized settings (FiO2 0.4, PEEP 5)

---

c) Extended Criteria Lung Donors (4 marks)

Definition (2 marks):

• Age >55 years (0.5)
• Smoking history >20 pack-years (0.5)
• PaO2/FiO2 200-300 mmHg (0.5)
• CXR abnormalities/infiltrates (0.5)

Counseling the Transplant Team (2 marks):

• Current PaO2/FiO2 = 180 (extended criteria) (0.5)
• Potential for improvement with optimization (recruitment, diuresis, time) (0.5)
• Suggest serial assessment after 12-24 hours of aggressive management (0.5)
• May consider ex vivo lung perfusion (EVLP) at transplant center to assess and optimize lungs before transplantation (0.5)

---

CICM Viva Scenarios

Viva 1: Refractory Hypotension in Potential Organ Donor

Scenario: You are managing a 52-year-old potential organ donor who was declared brain dead 4 hours ago following a large intracerebral hemorrhage. The family has consented to donation. Despite noradrenaline 0.4 mcg/kg/min, the MAP remains 55 mmHg. Urine output is 800 mL/h, sodium is 158 mmol/L, and temperature is 33.8°C.

---

Examiner: What is your assessment of this patient's hemodynamic status?

Candidate: This patient has refractory hypotension in the context of established brain death. The combination of findings suggests:

1. Diabetes insipidus (DI): Polyuria (800 mL/h) with hypernatremia (158 mmol/L) indicates ADH deficiency, which is present in 70-90% of brain-dead donors

2. Hypovolemia: The massive urinary losses have caused significant intravascular volume depletion, contributing to hypotension

3. Catecholamine depletion: High noradrenaline requirements (0.4 mcg/kg/min) with poor response suggests catecholamine depletion following the autonomic storm

4. Hypothermia: Temperature 33.8°C indicates loss of hypothalamic thermoregulation, which impairs drug metabolism and catecholamine responsiveness

5. Possible myocardial dysfunction: May have catecholamine-induced myocardial stunning from the initial storm

---

Examiner: What is your immediate management plan?

Candidate: My immediate priorities are:

1. Initiate Vasopressin:

• Start vasopressin 1-2 units/hour IV infusion
• This addresses both DI (V2 receptor - water reabsorption) and hypotension (V1 receptor - vasoconstriction)
• Evidence shows vasopressin reduces catecholamine requirements by 30-50%

2. Volume Resuscitation:

• Replace urinary losses with hypotonic fluids (0.45% saline or 5% dextrose)
• Calculate free water deficit and replace
• Initially match output mL-for-mL, then titrate as DI comes under control
• Target CVP 4-10 mmHg

3. Active Warming:

• Forced-air warming blanket (Bair Hugger)
• Warm IV fluids
• Increase ambient temperature
• Target >35.5°C

4. Wean Noradrenaline:

• As vasopressin takes effect, gradually reduce noradrenaline
• Target <0.1 mcg/kg/min (high doses impair graft function)

5. Methylprednisolone:

• 15 mg/kg IV (up to 1,000 mg) if not already given
• Improves catecholamine responsiveness and reduces inflammation

---

Examiner: The MAP improves to 68 mmHg on vasopressin 3 units/h and noradrenaline 0.15 mcg/kg/min. An echocardiogram shows EF 35% with global hypokinesis. How does this affect your management?

Candidate: This finding is consistent with catecholamine-induced myocardial stunning, which occurs in 30-50% of brain-dead donors.

My approach:

1. Understand the context: The catecholamine storm causes direct myocardial injury (contraction band necrosis, calcium overload), but this is often reversible

2. Inotropic support: Add dobutamine 2-5 mcg/kg/min to support cardiac output while myocardium recovers

3. Serial echocardiography: Repeat echo at 12-24 hours - 70-80% of stunned hearts recover to EF >45% with optimal management

4. Consider T3: Although the Pfeifer 2023 NEJM trial showed no overall benefit, ANZICS guidelines suggest selective use in cardiac donors with EF <45%

   • Dose: T3 4 mcg bolus, then 3 mcg/h infusion

5. Optimize preload: Ensure adequate but not excessive filling (CVP 6-10 mmHg)

6. Minimize catecholamines: Continue weaning noradrenaline; high doses worsen myocardial stunning

7. Communicate with transplant team: Inform cardiac transplant team of current EF but emphasize potential for recovery; this may still be a suitable cardiac donor after optimization

---

Examiner: What evidence informs the use of hormonal resuscitation?

Candidate: The evidence base is mixed:

Supporting Hormonal Resuscitation:

• Rosendale 2003: Retrospective analysis of UNOS database showed hormonal resuscitation (T3 + vasopressin + methylprednisolone) increased cardiac procurement by 22% and organs per donor by 0.5

Challenging T3/T4 Specifically:

• Pfeifer 2023 (NEJM): Randomized 1,121 brain-dead donors to T4 (levothyroxine) vs placebo
  • No difference in organs transplanted per donor
  • No difference in hearts transplanted
  • No improvement in hemodynamics or vasopressor requirements
  • "Conclusion: T4 provides no benefit"

Strong Evidence Components:

• Methylprednisolone: Multiple studies show benefit; reduces inflammation, improves lung procurement by 20-30%
• Vasopressin: Reduces catecholamine requirements, improves outcomes

Current Recommendation (ANZICS/TSANZ):

• Methylprednisolone: Recommended for all
• Vasopressin: Recommended for all with DI or hypotension
• T3/T4: Selective use only (cardiac donors with EF <45%)

---

Viva 2: Communication with Aboriginal Family

Scenario: A 28-year-old Aboriginal man from a remote community in the Northern Territory has been declared brain dead following a motor vehicle collision. He is a registered organ donor. His extended family has gathered at the hospital, including several Elders.

---

Examiner: How would you approach communication with this family?

Candidate: This requires a culturally sensitive approach that respects Aboriginal protocols and decision-making processes.

Preparation:

1. Involve Aboriginal Liaison Officer (ALO) or Aboriginal Health Worker (AHW) before any family meeting
2. Identify key decision-makers (likely Elders rather than immediate family alone)
3. Arrange private, appropriate space for large family gathering
4. Allow significantly more time than standard family meetings
5. Consider whether interpreter services are needed

Communication Principles:

1. Decoupled approach: Clearly confirm death before any mention of donation
2. Use clear, simple language avoiding medical jargon
3. Allow extended silences - these are culturally appropriate
4. Understand that community consultation may be required before decisions
5. Respect that different Aboriginal communities have different protocols

---

Examiner: The family asks if they can take him home to Country before any organ retrieval. How do you respond?

Candidate: This is an important cultural request that I would approach with respect and sensitivity.

My response: "I understand the importance of Country for your family and community. This is something we want to support as much as possible."

I would explain:

1. The practical constraints of organ donation (organs remain viable for limited time)
2. Explore what aspects of connection to Country might be achievable (symbols, items, family performing ceremonies at bedside)

I would offer alternatives:

1. Cultural liaison to facilitate appropriate ceremonies at the hospital
2. Return of the body to Country immediately after organ retrieval
3. Spiritual care support
4. Extended time for family and community to be with him

I would emphasize:

• The family's decision will be respected whatever they choose
• No pressure to proceed with donation
• Support available regardless of decision

---

Examiner: The Elders consent to donation but one of his parents is opposed. How do you manage this conflict?

Candidate: This situation requires careful navigation of both legal requirements and cultural protocols.

Understanding the dynamics:

1. In Aboriginal culture, Elders often hold decision-making authority over individual family members
2. However, Australian law recognizes specific next-of-kin hierarchy

My approach:

1. Facilitate discussion: Provide private space for family to discuss among themselves
2. Seek consensus: The ideal outcome is family agreement
3. Explore the parent's concerns: Understanding their objection may help address it
4. Cultural support: ALO/AHW may help mediate within cultural norms
5. Time: Allow extended time for discussion and potential community consultation

If consensus cannot be reached:

• Legally, the parent (as next-of-kin) has authority
• Donation typically would not proceed if a parent objects
• Document the situation and decision
• Provide bereavement support to all family members

I would not:

• Pressure any family member
• Undermine the Elders' cultural authority
• Rush the decision-making process